EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, vol.116, no.3, pp.143-147, 2008 (Journal Indexed in SCI)
Objective: We aimed to assess circulating thrombin activatable fibrinolysis inhibitor (TAFI) levels and carotid intima-media thickness (CIMT) in PCOS patients and control sujects. in this study we aimed to evaluate the relation between the levels of TAFI and homocysteine, high sensitive CRP (hsCRP), fibrinogen and CIMT in PCOS patients carrying a potential risk for developing CVD and diabetes and compared with age- and body mass index-matched controls.